Mr. Navarro, you mentioned that it's rare to invest in Canadian companies, or that there are some issues associated with that.
I had the opportunity to be with the Minister of Science in Germany last week. We were talking to research organizations. What they were talking about was how you get business engaged in research.
Of course, if you're in Germany, that's where everybody wants to go. If you're in the U.S., that's where the critical mass is. How does a country such as Canada manage to deal with this when we have obstacles such as our geography, where you're looking at six hours to fly from one side to the other; the jurisdictional aspects, when you have provincial regulations that all have to be dealt with; and, of course, the proximity to a larger market? Even though Canadians and the Canadian government over the years have invested in research for universities at the same rate the Germans have, these are some of the reasons why we don't get the overall dollars: because companies aren't prepared to engage.
I'm wondering if angel investors have that same sort of concern: are we really going to put it into the Canadian market? Will they do that if they know they can move it to places outside of Canada?